Contrast Induced Nephropathy (CIN) Completed Phase 4 Trials for Sodium bicarbonate (DB01390)

Also known as: Contrast Induced Nephropathy

IndicationStatusPhase
DBCOND0066353 (Contrast Induced Nephropathy (CIN))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00639912Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction.Treatment
NCT00770614Hydration and Contrast-Induced Nephropathy in Primary AngioplastyPrevention